Showing 25 to 36 of 50 results
Kennedy Replaces Entire CDC Vaccine Advisory Committee
HHS Secretary Robert F. Kennedy Jr. replaced all 17 members of the CDC's vaccine advisory committee (ACIP) on Monday, citing concerns about conflicts of interest and a need to restore public trust; this decision has drawn sharp criticism from health experts and organizations who warn of potential ne...
Kennedy Replaces Entire CDC Vaccine Advisory Committee
HHS Secretary Robert F. Kennedy Jr. replaced all 17 members of the CDC's vaccine advisory committee (ACIP) on Monday, citing concerns about conflicts of interest and a need to restore public trust; this decision has drawn sharp criticism from health experts and organizations who warn of potential ne...
Progress
56% Bias Score
FDA Mandates Updated Covid-19 Vaccine Warning Labels
The FDA mandates updated Covid-19 vaccine warning labels for Pfizer-BioNTech and Moderna, specifying a slightly increased risk of myocarditis/pericarditis in males aged 16-25 based on health insurance claims data analysis showing 38 cases per million doses, highlighting the importance of transparenc...
FDA Mandates Updated Covid-19 Vaccine Warning Labels
The FDA mandates updated Covid-19 vaccine warning labels for Pfizer-BioNTech and Moderna, specifying a slightly increased risk of myocarditis/pericarditis in males aged 16-25 based on health insurance claims data analysis showing 38 cases per million doses, highlighting the importance of transparenc...
Progress
48% Bias Score
FDA Approves Novavax Covid-19 Vaccine for Specific High-Risk Groups
The FDA approved Novavax's protein-based Covid-19 vaccine for those 65 and older and individuals 12 and older with underlying conditions, after a six-week delay to gather more data and mandate post-marketing safety studies on rare heart inflammation risks.
FDA Approves Novavax Covid-19 Vaccine for Specific High-Risk Groups
The FDA approved Novavax's protein-based Covid-19 vaccine for those 65 and older and individuals 12 and older with underlying conditions, after a six-week delay to gather more data and mandate post-marketing safety studies on rare heart inflammation risks.
Progress
48% Bias Score
HHS Mandates Placebo Testing for All New Vaccines, Sparking Expert Concerns
The US Department of Health and Human Services (HHS) plans to mandate placebo testing for all new vaccines, a move that experts warn could limit vaccine availability and raise ethical concerns, despite the agency citing a need for greater transparency.
HHS Mandates Placebo Testing for All New Vaccines, Sparking Expert Concerns
The US Department of Health and Human Services (HHS) plans to mandate placebo testing for all new vaccines, a move that experts warn could limit vaccine availability and raise ethical concerns, despite the agency citing a need for greater transparency.
Progress
52% Bias Score
HHS Mandates Placebo Trials for All New Vaccines, Raising Concerns for COVID-19 Updates
The U.S. HHS announced that all new vaccines will require placebo-controlled trials before authorization, potentially delaying updated COVID-19 vaccines and raising questions about current vaccine safety monitoring systems.
HHS Mandates Placebo Trials for All New Vaccines, Raising Concerns for COVID-19 Updates
The U.S. HHS announced that all new vaccines will require placebo-controlled trials before authorization, potentially delaying updated COVID-19 vaccines and raising questions about current vaccine safety monitoring systems.
Progress
52% Bias Score
HHS Mandates Placebo Trials for New Vaccines, Delaying COVID-19 Boosters
The US Department of Health and Human Services announced Wednesday that all new vaccines will require placebo-controlled trials before licensure, a change that experts warn could delay updated COVID-19 vaccines by months and put vulnerable populations at risk, despite assertions that current safety ...
HHS Mandates Placebo Trials for New Vaccines, Delaying COVID-19 Boosters
The US Department of Health and Human Services announced Wednesday that all new vaccines will require placebo-controlled trials before licensure, a change that experts warn could delay updated COVID-19 vaccines by months and put vulnerable populations at risk, despite assertions that current safety ...
Progress
52% Bias Score
Trump Administration Terminates $750 Million in Funding for Moderna's mRNA Bird Flu Vaccine
The Trump administration terminated over $750 million in funding for Moderna's mRNA bird flu vaccine development, citing safety and ethical concerns, following previous funding from the Biden administration totaling $766 million; this reflects a broader policy shift prioritizing older populations an...
Trump Administration Terminates $750 Million in Funding for Moderna's mRNA Bird Flu Vaccine
The Trump administration terminated over $750 million in funding for Moderna's mRNA bird flu vaccine development, citing safety and ethical concerns, following previous funding from the Biden administration totaling $766 million; this reflects a broader policy shift prioritizing older populations an...
Progress
64% Bias Score
FDA Expands COVID-19 Vaccine Warnings for Myocarditis Risk in Young Men
The FDA is expanding warning labels on Pfizer and Moderna's COVID-19 vaccines to include a higher risk of myocarditis and pericarditis in males aged 16-25, citing a rate of 38 cases per million doses compared to 8 per million in other groups, based on a study published last year and new agency data....
FDA Expands COVID-19 Vaccine Warnings for Myocarditis Risk in Young Men
The FDA is expanding warning labels on Pfizer and Moderna's COVID-19 vaccines to include a higher risk of myocarditis and pericarditis in males aged 16-25, citing a rate of 38 cases per million doses compared to 8 per million in other groups, based on a study published last year and new agency data....
Progress
64% Bias Score
New HHS Vaccine Rule Risks Delaying Fall Covid-19 Booster Rollout
HHS Secretary Robert F. Kennedy Jr.'s new rule mandates placebo-controlled trials for all new vaccines, potentially delaying the fall rollout of updated Covid-19 vaccines from Pfizer and Moderna by months, according to vaccine experts, due to the time needed for new trials and analysis; the FDA is e...
New HHS Vaccine Rule Risks Delaying Fall Covid-19 Booster Rollout
HHS Secretary Robert F. Kennedy Jr.'s new rule mandates placebo-controlled trials for all new vaccines, potentially delaying the fall rollout of updated Covid-19 vaccines from Pfizer and Moderna by months, according to vaccine experts, due to the time needed for new trials and analysis; the FDA is e...
Progress
64% Bias Score
New Vaccine Testing Requirement Risks Delaying COVID-19 and Other Vaccines
The Trump administration's new requirement for placebo-controlled trials of all new vaccines, opposed by many experts, threatens to delay the next round of COVID-19 vaccines and other vaccine approvals, raising ethical and practical concerns.
New Vaccine Testing Requirement Risks Delaying COVID-19 and Other Vaccines
The Trump administration's new requirement for placebo-controlled trials of all new vaccines, opposed by many experts, threatens to delay the next round of COVID-19 vaccines and other vaccine approvals, raising ethical and practical concerns.
Progress
56% Bias Score
HHS Mandates Placebo Trials for All New Vaccines, Raising Covid-19 Booster Concerns
The US Department of Health and Human Services mandated placebo-controlled trials for all new vaccines before licensure, impacting Covid-19 booster distribution timelines and raising concerns among experts about increased risks to vulnerable populations, particularly the elderly (over 36,000 deaths ...
HHS Mandates Placebo Trials for All New Vaccines, Raising Covid-19 Booster Concerns
The US Department of Health and Human Services mandated placebo-controlled trials for all new vaccines before licensure, impacting Covid-19 booster distribution timelines and raising concerns among experts about increased risks to vulnerable populations, particularly the elderly (over 36,000 deaths ...
Progress
60% Bias Score
Reunion Island Chikungunya Vaccine Suspended for Seniors After Adverse Events
Due to three serious adverse events in individuals over 80 with comorbidities, France suspended the chikungunya vaccine for those over 65 on Reunion Island, shifting focus to 18-65 year olds with specific health conditions; nine deaths have been reported amidst a major outbreak.
Reunion Island Chikungunya Vaccine Suspended for Seniors After Adverse Events
Due to three serious adverse events in individuals over 80 with comorbidities, France suspended the chikungunya vaccine for those over 65 on Reunion Island, shifting focus to 18-65 year olds with specific health conditions; nine deaths have been reported amidst a major outbreak.
Progress
36% Bias Score
Showing 25 to 36 of 50 results